4grl:D (VAL178) to (GLY264) CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX | IMMUNE COMPLEX, PEPTIDE ANTIGEN PRESENTATION, MULTIPLE SCLEROSIS, AUTOIMMUNITY, IMMUNE SYSTEM
4grm:D (HIS156) to (ALA245) THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6 | HIGH-AFFINITY TCR, C134 MODIFICATION, TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, IMMUNE SYSTEM
4gsd:L (GLY143) to (PRO209) H5.3 FAB STRUCTURE | ANTIBODY, IMMUNE RESPONSE, INFLUENZA H5 HEMAGGLUTANIN, IMMUNE SYSTEM
1a3l:H (PRO151) to (LYS222) CATALYSIS OF A DISFAVORED REACTION: AN ANTIBODY EXO DIELS- ALDERASE-TSA-INHIBITOR COMPLEX AT 1.95 A RESOLUTION | DIELS-ALDER, DISFAVORED REACTION, CATALYTIC ANTIBODY, IMMUNOGLOBULIN
1a8j:H (GLY146) to (PRO212) IMMUNOGLOBULIN LAMBDA LIGHT CHAIN DIMER (MCG) COMPLEX WITH ASPARTAME | ASPARTAME, LIGAND BINDING, IMMUNOTHERAPEUTIC AGENT, SURROGATE RECEPTOR, MCG(HUMAN) BENCE-JONES DIMER, IMMUNOGLOBULIN
4wi2:B (ASP376) to (LEU443) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE) | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
4wi7:A (PRO271) to (LYS338) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
4wi8:B (ASP376) to (LEU443) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
4gxu:N (THR145) to (PRO208) CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1ngp:L (THR148) to (ARG211) N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3- NITROPHENYL) ACETATE | IMMUNOGLOBULIN,
1ngq:L (THR148) to (ARG211) N1G9 (IGG1-LAMBDA) FAB FRAGMENT | IMMUNOGLOBULIN,
2ojz:I (PRO151) to (PRO227) ANTI-DNA ANTIBODY ED10 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
2old:B (THR150) to (PRO213) BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(2)21 CRYSTAL FORM | IMMUNOGLOBULIN LIGHT CHAIN, IMMUNE SYSTEM
2omb:B (ALA148) to (ALA212) BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(1)21 CRYSTAL FORM | IMMUNOGLOBULIN LIGHT CHAIN, IMMUNE SYSTEM
4wnq:B (HIS163) to (TRP249) THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION | IMMUNITY, IMMUNE SYSTEM
2op4:L (THR145) to (ARG211) CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9 | IMMUNOGLOBULIN, ANTIBODY, FAB, INDUCED FIT, QUORUM SENSING, HOMOSERINE LACTONE, IMMUNE SYSTEM
4wo4:D (HIS163) to (GLY250) THE MOLECULAR BASES OF DELTA/ALPHA BETA T CELL-MEDIATED ANTIGEN RECOGNITION. | IMMUNITY, IMMUNE SYSTEM
3rwd:A (GLU212) to (TRP274) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW11 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwe:A (GLU212) to (TRP274) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-FW9 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwf:A (GLU212) to (TRP274) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-QW9 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwg:A (GLU212) to (TRP274) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MW9 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwh:A (GLU212) to (TRP274) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MF8 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwh:D (GLU212) to (TRP274) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MF8 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwj:A (GLU212) to (TRP274) RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-HW8 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rzc:D (HIS151) to (TRP237) STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
3eo0:B (PRO156) to (PRO220) STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008 | CYTOKINE NEUTRALIZING ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
3eo0:D (PRO156) to (PRO220) STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008 | CYTOKINE NEUTRALIZING ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
2oz4:H (PRO150) to (PRO213) STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION | IGSF DOMAIN, STRUCTURAL PLASTICITY, CELL-SURFACE DIMERIZATION, CELL ADHESION
4ww1:B (HIS164) to (ALA253) CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 AND BETA CHAIN-TRBV7-8 | IMMUNITY, NKT CELLS, IMMUNE SYSTEM
4ww2:B (HIS164) to (GLY251) CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8, BETA CHAIN- TRBV7-8, ANTIGEN-PRESENTING GLYCOPROTEIN CD1D, AND BETA-2- MICROGLOBULIN | NATURAL KILLER T CELLS, IMMUNITY, IMMUNE SYSTEM
4wwk:B (HIS165) to (GLY252) CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV12-3, BETA CHAIN-TRBV6- 5, ANTIGEN-PRESENTING MOLECULE CD1D, AND BETA-2-MICROGLOBULIN | INNATE IMMUNITY, NKT, IMMUNE SYSTEM
2p5e:E (HIS151) to (ALA240) CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY | T-CELL RECEPTOR, CDR3, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
2p5w:E (HIS151) to (ALA240) CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY | T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
3s36:H (PRO152) to (PRO216) STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES | ANTIBODY, KDR, VEGF RECEPTOR, CANCER, IMMUNE SYSTEM-TRANSFERASE COMPLEX
1bjm:A (THR149) to (PRO212) LOC NAKS, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN NAKSO4 | BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES, IMMUNOGLOBULIN
1bjm:B (THR149) to (PRO212) LOC NAKS, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN NAKSO4 | BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES, IMMUNOGLOBULIN
1bqh:D (ASP212) to (TRP274) MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8 | T-CELL, CORECEPTOR, GLYCOPROTEIN, COMPLEX, IMMUNOLOGY, ANTIGEN, IMMUNE SYSTEM
4x6c:F (HIS155) to (TRP241) CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR | CD1A, TCR, IMMUNE COMPLEX, LIPID ANTIGEN, IMMUNE SYSTEM
4x6c:H (HIS155) to (ALA244) CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR | CD1A, TCR, IMMUNE COMPLEX, LIPID ANTIGEN, IMMUNE SYSTEM
3s7g:C (ASP376) to (LEU443) AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT | AGLYCOSYLATED, FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN
2brr:H (PRO149) to (LYS208) COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34) | IMMUNE SYSTEM, FAB FRAGMENT, ANTI-PORA ANTIBODY, P1.4 ANTIBODY, ANTIGEN, PORIN, TRANSMEMBRANE, ANTIBODY/ANTIGEN COMPLEX
4x7t:L (ALA148) to (GLY216) STRUCTURE OF OMALIZUMAB FAB FRAGMENT, CRYSTAL FORM 2 | ANTIBODY FAB FRAGMENT, ANTI-IGE ANTIBODY, ANTI-INFLAMMATORY, IMMUNE SYSTEM
4x99:B (ILE377) to (LEU443) IMMUNOGLOBULIN FC HETERODIMERS VARIANT | BISPECIFIC ANTIBODY, IMMUNOGLOBULIN FC HETERODIMER, CH3 DOMAIN INTERFACE, ASYMMETRIC DISULFIDE BONDS, THERMAL STABILITY, FC ENGINEERING, IMMUNE SYSTEM
4xc1:H (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SN-GLYCEROL 3- PHOSPHATE | HIV-1 GP41 MPER, 4E10 FAB, LIPID MEMBRANE, IMMUNE SYSTEM
3sdc:D (HIS157) to (TRP243) CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE | CD1D, AUTOIMMUNITY, SELF-RECOGNITION, NKT, IMMUNE SYSTEM
1c5c:H (PRO151) to (PRO227) DECARBOXYLASE CATALYTIC ANTIBODY 21D8-HAPTEN COMPLEX | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, DECARBOXYLASE, HAPTEN COMPLEX, IMMUNE SYSTEM
2po6:D (HIS157) to (ALA246) CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN, NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN | CD1D-LIPID ANTIGEN NKT15 COMPLEX, LIPID BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
3sgj:A (ASP376) to (SER440) UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE | RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM
3fmg:H (PRO161) to (LYS232) STRUCTURE OF ROTAVIRUS OUTER CAPSID PROTEIN VP7 TRIMER IN COMPLEX WITH A NEUTRALIZING FAB | ANTIBODY-ANTIGEN COMPLEX, CALCIUM DEPENDENT TRIMER, ANTIPARALLEL BETA-SANDWICH, JELLY ROLL, ALPHA-BETA-ALPHA SANDWICH, ROSSMANN FOLD, CAPSID PROTEIN, ENDOPLASMIC RETICULUM, GLYCOPROTEIN, MEMBRANE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM
3fol:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFERI | CLASS I MHC, PEPTIDE COMPLEX, DIABETES-PROTECTIVE EFFECT, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, SECRETED, CHROMOSOMAL PROTEIN, DNA-BINDING, METHYLATION, NUCLEOSOME CORE, NUCLEUS, PHOSPHOPROTEIN, IMMUNE SYSTEM
2pye:A (GLU212) to (TRP274) CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC | T-CELL RECEPTOR, CDR3, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
2pye:E (HIS151) to (ALA240) CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC | T-CELL RECEPTOR, CDR3, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
3fqn:A (GLU212) to (TRP274) PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES | IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE
3fqw:A (GLU212) to (TRP274) PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES | IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE
3fqx:A (GLU212) to (TRP274) PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES | IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE
3ft2:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF A CITRULLINE PEPTIDE VARIANT OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1 IN COMPLEX WITH HLA- A2 | HLA, HUMAN MINOR H ANTIGENS, ANTIGEN PROCESSING, ANTIGEN PRESENTATION, IMMUNE RESPONSE, IMMUNOGENICITY, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, GRAFT REJECTION, HOST-VERSUS-GRAFT DISEASE, GRAFT-VERSUS- TUMOR IMMUNE SYSTEM
3ft4:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1ARG IN COMPLEX WITH HLA-A2 | HLA, HUMAN MINOR H ANTIGENS, ANTIGEN PROCESSING, ANTIGEN PRESENTATION, IMMUNE RESPONSE, IMMUNOGENICITY, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, GRAFT REJECTION, HOST-VERSUS-GRAFT DISEASE, GRAFT-VERSUS- TUMOR IMMUNE SYSTEM
2cde:B (HIS155) to (TRP241) STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR | CELL RECEPTOR, T CELL RECEPTOR, TCR, NATURAL KILLER T CELL, CD1D, ALPHA- GALACTOSYLCERAMIDE, MHC CLASS I
2cde:D (HIS155) to (TRP241) STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR | CELL RECEPTOR, T CELL RECEPTOR, TCR, NATURAL KILLER T CELL, CD1D, ALPHA- GALACTOSYLCERAMIDE, MHC CLASS I
2cdg:B (HIS156) to (ASP246) STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5B) | RECEPTOR, CD1D, MHC CLASS I, TCR 5B
4xnq:A (GLY141) to (ALA206) ANTIBODY HEMAGGLUTININ COMPLEXES | ANTIBODY, HEMAGGLUTININ, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2qej:A (VAL277) to (LYS340) CRYSTAL STRUCTURE OF A STAPHYLOCOCCUS AUREUS PROTEIN (SSL7) IN COMPLEX WITH FC OF HUMAN IGA1 | IGA1, ANTIBODY, IMMUNOGLOBULIN, OB-FOLD, BETA-GRASP, SSL, IMMUNE SYSTEM
3g6a:L (GLY143) to (PRO209) CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY CNTO607 | IL-13, ANTIBODY, FAB, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4irs:D (HIS151) to (TRP237) STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
4xvu:K (PRO158) to (PRO222) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
1dqq:B (PRO149) to (LYS220) CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63 | ANTI-LYSOZYME ANTIBODY, HYHEL-63, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM
1dqq:D (PRO149) to (LYS220) CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63 | ANTI-LYSOZYME ANTIBODY, HYHEL-63, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM
2qri:B (ASP212) to (TRP274) CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB WT, BETA-2MICROGLOBULIN, AND OVALBUMIN-DERIVED PEPTIDE. | MHC-I, OVA, SINGLE CHAIN MHC-I, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM
3ghb:L (GLY142) to (ALA207) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020 | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE PROTEIN, IMMUNE SYSTEM
3gje:L (GLY145) to (PRO211) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | ANTIBODY, PMHC, IMMUNE RECOGNITION, IMMUNE SYSTEM
3gje:A (GLY145) to (PRO211) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | ANTIBODY, PMHC, IMMUNE RECOGNITION, IMMUNE SYSTEM
3ta3:D (HIS151) to (TRP237) STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
4y1a:E (HIS165) to (ALA254) IMMUNE COMPLEX | TCR MHC, IMMUNE SYSTEM
4y2d:D (HIS151) to (TRP237) CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX | MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM
4y2d:H (HIS151) to (TRP237) CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX | MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM
4y4f:D (HIS151) to (TRP237) CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX | MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR
4y4k:D (HIS151) to (TRP237) CRYSTAL STRUCTURE OF THE MCD1D/EF77/INKTCR TERNARY COMPLEX | MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM
4j4p:H (PRO182) to (PRO246) THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS | IG LIKE DOMAIN, IMMUNE SYSTEM
3gsr:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5V PEPTIDE VARIANT | HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1q1j:L (GLY142) to (PRO211) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE | FAB-PEPTIDE COMPLEX, HIV-1, GP120, V3 LOOP, IMMUNE SYSTEM
1q1j:M (GLY142) to (PRO211) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE | FAB-PEPTIDE COMPLEX, HIV-1, GP120, V3 LOOP, IMMUNE SYSTEM
4j8r:D (PRO148) to (LYS208) STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT | IMMUNOGLOBULIN FOLD, FAB, ANTIBODY, OCTAPEPTIDE REPEAT, MOUSE PRION PROTEIN, IMMUNE SYSTEM
3thm:L (GLY146) to (ALA211) CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB EP6B_B01 | AGONISTIC ANTIBODY, FAB FRAGMENT, ANTIBODY-RECEPTOR COMPLEX, TUMOR NECROSIS FACTOR RECEPTOR, CYSTEINE-RICH DOMAIN, FAS, IMMUNE SYSTEM
3tjh:D (HIS151) to (TRP237) 42F3-P3A1/H2-LD COMPLEX | IG MHC, ANTIGEN RECOGNITION, TCR-PMHC, MEMBRANE RECEPTOR, IMMUNE SYSTEM
1q94:D (GLU212) to (TRP274) STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE | IMMUNE SYSTEM
4jfe:E (HIS154) to (TRP240) PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR | HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY
3tnm:B (THR145) to (PRO208) CRYSTAL STRUCTURE OF A32 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY | ADCC, NON-NEUTRALIZING, ANTI-HIV-1 ENV ANTIBODY A32, CD4I ANTIBODY, FAB, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, IMMUNE SYSTEM
3to2:A (GLU212) to (TRP274) STRUCTURE OF HLA-A*0201 COMPLEXED WITH PEPTIDE MD3-C9 DERIVED FROM A CLUSTERING REGION OF RESTRICTED CYTOTOXIC T LYMPHOCYTE EPITOPE FROM SARS-COV M PROTEIN | PRESENTATION, HLA, CTL EPITOPE, IMMUNE SYSTEM
1qbm:H (PRO153) to (PRO216) FAB E8B ANTIBODY, X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN, IGG1 KAPPA, ANTIBODY, FAB FRAGMENT, ANTI- CYTOCHROME C ANTIBODY
3tpu:B (HIS151) to (TRP237) 42F3 P5E8/H2-LD COMPLEX | IG MHC, ANTIGEN RECOGNITION, TCR-PMHC, CHIMERA PROTEIN, MEMBRANE RECEPTOR, IMMUNE SYSTEM
3tpu:D (HIS151) to (TRP237) 42F3 P5E8/H2-LD COMPLEX | IG MHC, ANTIGEN RECOGNITION, TCR-PMHC, CHIMERA PROTEIN, MEMBRANE RECEPTOR, IMMUNE SYSTEM
3tpu:N (HIS151) to (ALA240) 42F3 P5E8/H2-LD COMPLEX | IG MHC, ANTIGEN RECOGNITION, TCR-PMHC, CHIMERA PROTEIN, MEMBRANE RECEPTOR, IMMUNE SYSTEM
3tv3:L (THR145) to (ALA210) CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9 | FAB, HIV-1 NEUTRALIZING ANTIBODY, GP120, IMMUNE SYSTEM
4jn2:H (PRO159) to (PRO223) AN ANTIDOTE FOR DABIGATRAN | IGG FRAGMENT BINDING DABIGATRAN, DABIGATRAN, IMMUNE SYSTEM-INHIBITOR COMPLEX
3tvm:D (HIS151) to (ALA240) STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
3tvm:H (HIS151) to (TRP237) STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
4jry:E (HIS166) to (TRP252) CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX | TCR, T CELL, HLA B*3508, LPEP, EBV, ALLOREACTIVITY, IMMUNE SYSTEM
3tyf:D (HIS157) to (TRP243) CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR | IMMUNOGLOBULIN-LIKE, ANTIGEN RECOGNITION, CD1D, MEMBRANE, IMMUNE SYSTEM
1qse:E (HIS156) to (ALA245) STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R | HUMAN T CELL RECEPTOR, TCR/PEPTIDE/MHC COMPLEX, HLA-A2, IMMUNE SYSTEM
3tzv:B (HIS157) to (ALA246) CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE | IMMUNOGLOBULIN-LIKE, MHC CLASS I-LIKE, ANTIGEN RECOGNITION, CD1D, CELL SURFACE, IMMUNE SYSTEM
3tzv:H (HIS157) to (ALA246) CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE | IMMUNOGLOBULIN-LIKE, MHC CLASS I-LIKE, ANTIGEN RECOGNITION, CD1D, CELL SURFACE, IMMUNE SYSTEM
1f4w:L (THR148) to (SER210) CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN | ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
1f4x:L (THR148) to (SER210) CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN | ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
3hae:G (ALA146) to (PRO211) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3hae:H (PRO155) to (PRO219) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
2uwe:H (GLU212) to (TRP274) LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION | HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM, MHC I, MEMBRANE, RECEPTOR, CLASS I MHC, HYPOTHETICAL PROTEIN, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN, IMMUNE RESPONSE, TCR-PMHC COMPLEX, T CELL SIGNALING, DISEASE MUTATION
3hi6:H (PRO156) to (SER220) CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57 | INTEGRIN, I DOMAIN, FAB, LIGAND MIMETIC ANTIBODY, CELL ADHESION, ALTERNATIVE SPLICING, CALCIUM, DISULFIDE BOND, GLYCOPROTEIN, MAGNESIUM, MEMBRANE, POLYMORPHISM, RECEPTOR, TRANSMEMBRANE, CELL ADHESION/IMMUNE SYSTEM COMPLEX
2esv:E (HIS157) to (GLY244) STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX | T CELL RECEPTOR, TCR, HLA-E, CMV, PMHC/TCR COMPLEX, IMMUNE SYSTEM
4k3d:L (GLY142) to (LYS207) CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3 | IMMUNOGLOBULIN, CYSTINE KNOT, IMMUNE RECOGNITION, IMMUNE SYSTEM
4k3d:M (GLY142) to (LYS207) CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3 | IMMUNOGLOBULIN, CYSTINE KNOT, IMMUNE RECOGNITION, IMMUNE SYSTEM
4k3e:M (GLY142) to (THR205) CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3 | IMMUNOGLOBULIN; CYSTINE KNOT, IMMUNE RECOGNITION, IMMUNE SYSTEM
3hkf:A (GLN277) to (SER340) MURINE UNGLYCOSYLATED IGG FC FRAGMENT | ANTIBODY, GLYCOSYLATION, STABILITY, IMMUNE SYSTEM
2eyr:B (HIS157) to (GLY244) A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION | NATURAL KILLER T CELL RECEPTOR, NKT CELL RECEPTOR, NKT12, IMMUNE SYSTEM
2eys:B (HIS157) to (TRP243) A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION | NATURAL KILLER T CELL RECEPTOR, NKT CELL RECEPTOR, NKT15, IMMUNE SYSTEM
2eyt:B (HIS157) to (TRP243) A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION | NATURAL KILLER T CELL RECEPTOR, NKT CELL RECEPTOR, NKT15, IMMUNE SYSTEM
2eyt:D (HIS157) to (TRP243) A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION | NATURAL KILLER T CELL RECEPTOR, NKT CELL RECEPTOR, NKT15, IMMUNE SYSTEM
1frg:H (PRO373) to (LYS433) CRYSTAL STRUCTURE, SEQUENCE, AND EPITOPE MAPPING OF A PEPTIDE COMPLEX OF AN ANTI-INFLUENZA HA PEPTIDE ANTIBODY FAB 26(SLASH)9: FINE-TUNING ANTIBODY SPECIFICITY | IMMUNOGLOBULIN/VIRUS HEMAGGLUTININ, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3ujj:L (GLY142) to (PRO208) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE | IG DOMAINS, ANTIBODY FAB, ANTIGEN BINDING, THE THIRD VARIABLE REGION OF HIV-1 GP120, IMMUNE SYSTEM
3ulv:H (PRO157) to (LYS217) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2) | TOLL-LIKE RECEPTOR-3, TLR3, INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
3ulv:C (ALA144) to (ALA208) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2) | TOLL-LIKE RECEPTOR-3, TLR3, INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
3ulv:F (PRO155) to (HIS219) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2) | TOLL-LIKE RECEPTOR-3, TLR3, INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
2f53:E (HIS151) to (ALA240) DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY | T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
2f54:E (HIS151) to (TRP237) DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY | T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, WILD TYPE SEQUENCE, HIGH AFFINITY, NY-ESO-1, IMMUNE SYSTEM
2f54:L (HIS151) to (TRP237) DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY | T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, WILD TYPE SEQUENCE, HIGH AFFINITY, NY-ESO-1, IMMUNE SYSTEM
1fyt:E (HIS157) to (ALA246) CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1 | PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1rzk:H (PRO149) to (PRO213) HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B | COMPLEX (HIV ENVELOPE PROTEIN-CD4-FAB); HIV-1 EXTERIOR ENVELOPE GP120 FROM LABORATORY-ADAPTED ISOLATE; HXBC2; SURFACE T-CELL GLYCOPROTEIN CD4; ANTIGEN-BINDING FRAGMENT OF HUMAN IMMUNOGLOBULIN 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1g9n:H (PRO164) to (LYS225) HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B | COMPLEX (HIV ENVELOPE PROTEIN-CD4-FAB), HIV-1 EXTERIOR ENVELOPE GP120 FROM CLINICAL PRIMARY ISOLATE, YU2, T-CELL SURFACE GLYCOPROTEIN CD4, ANTIGEN-BINDING FRAGMENT OF HUMAN IMMUNOGLOBULIN 17B, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
3utp:L (HIS156) to (ASP246) 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA | T CELL RECEPTOR, TYPE I DIABETES, IMMUNE SYSTEM
3utt:E (HIS156) to (TRP242) 1E6-A*0201-ALWGPDPAAA COMPLEX, TRICLINIC | MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, T CELL RECEPTOR, IMMUNE SYSTEM
4z7o:H (PRO155) to (LYS215) INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE | CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4z7q:H (PRO155) to (LYS215) INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE | CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4z7u:F (HIS167) to (ALA256) S13 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4z7u:H (HIS167) to (ALA256) S13 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4z7v:F (HIS167) to (ALA256) L3-12 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4z7v:H (HIS167) to (ALA256) L3-12 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4z7w:F (HIS167) to (TRP253) T316 COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4zak:D (HIS151) to (TRP237) CRYSTAL STRUCTURE OF THE MCD1D/DB06-1/INKTCR TERNARY COMPLEX | MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM
4zdh:B (HIS153) to (TRP239) CRYSTAL STRUCTURE OF JKA6 TCR | T-CELL RECEPTOR, IMMUNE SYSTEM
1sbb:A (HIS156) to (GLY243) T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SUPERANTIGEN SEB | T CELL RECEPTOR, SUPERANTIGEN, COMPLEX, IMMUNE SYSTEM
1sbb:C (HIS156) to (GLY243) T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SUPERANTIGEN SEB | T CELL RECEPTOR, SUPERANTIGEN, COMPLEX, IMMUNE SYSTEM
4zez:J (HIS151) to (TRP237) CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX | HCV TCR, HLA-A2, HCV NS3:1406-1415 PEPTIDE, DECAPEPTIDE, PROTEIN BINDING, IMMUNE SYSTEM COMPLEX, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
2vlr:E (HIS154) to (ASP244) THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN | IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX
2fx8:J (PRO151) to (PRO227) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
3v8c:A (ILE377) to (LEU443) CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) DOUBLE MUTANT (H310 AND H435 IN K) | FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM
1sm3:L (THR145) to (ARG208) CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE | ANTIBODY, PEPTIDE ANTIGEN, ANTITUMOR ANTIBODY, COMPLEX (ANTIBODY/PEPTIDE EPITOPE)
3vi4:F (PRO154) to (LYS214) CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE | BETA PROPELLER FOLD, ROSSMANN FOLD, BETA SANDWICH, FIBRONECTIN RECEPTOR, CELL ADHESION-IMMUNE SYSTEM COMPLEX
1t22:A (GLU212) to (TRP274) STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, ORTHORHOMBIC CRYSTAL | CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM
1h3t:A (ASP376) to (LEU443) CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (MN2F)2 | IMMUNOGLOBULIN, IMMUNE SYSTEM, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS
1t4k:D (PRO151) to (PRO227) CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB | ENANTIOSELECTIVITY, ALDOLASE ANTIBODY, REACTIVE LYSINE, ALDOL REACTION, IMMUNE SYSTEM
4l4t:E (HIS155) to (ALA244) STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP | MHC CLASS I-RELATED PROTEIN, MAIT TCR, IMMUNE SYSTEM, VITAMIN B METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4l4t:H (HIS155) to (ALA244) STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP | MHC CLASS I-RELATED PROTEIN, MAIT TCR, IMMUNE SYSTEM, VITAMIN B METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4l4v:H (HIS155) to (GLY242) STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH | MHC CLASS I-RELATED PROTEIN, MAIT TCR, IMMUNE SYSTEM, VITAMIN B METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4lcw:E (HIS155) to (ALA244) THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH | MHC CLASS I-RELATED PROTEIN, MAIT T CELL RECEPTOR, VITAMIN B2 METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4lcw:H (HIS155) to (GLY242) THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH | MHC CLASS I-RELATED PROTEIN, MAIT T CELL RECEPTOR, VITAMIN B2 METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
1tcr:B (HIS156) to (TRP242) MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE | T-CELL, RECEPTOR, TRANSMEMBRANE, GLYCOPROTEIN
3vrl:H (PRO158) to (LYS218) CRYSTAL STRUCTURE OF BMJ4 P24 CAPSID PROTEIN IN COMPLEX WITH A10F9 FAB | HIV-1 CAPSIDE P24, CAPSID PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
2hjf:A (PRO154) to (LYS214) POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA) | POTASSIUM CHANNEL, ION TRANSPORT, METAL TRANSPORT
5a16:A (PRO159) to (LYS219) CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1 | IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER
5a16:E (PRO159) to (LYS219) CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1 | IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER
1hzh:K (PRO284) to (LYS358) CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN, ANTIBODY, B12, IMMUNE SYSTEM
3vwj:D (HIS157) to (GLY244) TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX | CD1D, NKT T CELL RECEPTOR, ALPHA-GALACTOSYLCERAMIDE, PROTEIN RECEPTOR COMPLEX, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3vwk:D (HIS157) to (ALA246) TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4'DEOXY-ALPHA- GALACTOSYLCERAMIDE COMPLEX | CD1D, NKT T CELL RECEPTOR, ALPHA-GALACTOSYLCERAMIDE, PROTEIN RECEPTOR COMPLEX, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3vxn:A (GLU212) to (TRP274) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(WT) | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE
3vxo:A (GLU212) to (TRP274) HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(2F) | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE
3vxr:A (GLU212) to (TRP274) THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE
3vxt:B (HIS151) to (ALA240) T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10 | HIV-1, NEF, IMMUNE SYSTEM, T CELL RECEPTOR, IMMUNOGLOBURIN DOMAIN, TCR, IMMUNE RESPONSE
3vxu:J (VAL152) to (TRP237) THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE
3iyw:L (GLY150) to (PRO216) WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU) | VIRUS-ANTIBODY COMPLEX, NEUTRALIZING FAB FRAGMENT, FLAVIVIRUS, WEST NILE VIRUS, ENVELOPE PROTEIN, ICOSAHEDRAL VIRUS, VIRUS
3iyw:M (GLY150) to (PRO216) WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU) | VIRUS-ANTIBODY COMPLEX, NEUTRALIZING FAB FRAGMENT, FLAVIVIRUS, WEST NILE VIRUS, ENVELOPE PROTEIN, ICOSAHEDRAL VIRUS, VIRUS
1u8k:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
4m1d:L (GLY142) to (ALA207) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE, IMMUNE SYSTEM
2i60:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF [PHE23]M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, [PHE23]M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5a7x:D (PRO149) to (PRO213) NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN
5a7x:H (PRO149) to (PRO213) NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN
5a7x:L (PRO149) to (PRO213) NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN
5a8h:D (PRO149) to (PRO213) CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS
5a8h:J (PRO149) to (PRO213) CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS
5a8h:P (PRO149) to (PRO213) CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS
1im3:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX | BETA SHEET, BETA SANDWHICH, IMMUNOGLOBULIN (IG) FOLD, IMMUNOGLOBULIN (IG)-LIKE DOMAIN, PROTEIN COMPLEX, ALPHA HELIX, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
1im3:E (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX | BETA SHEET, BETA SANDWHICH, IMMUNOGLOBULIN (IG) FOLD, IMMUNOGLOBULIN (IG)-LIKE DOMAIN, PROTEIN COMPLEX, ALPHA HELIX, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
1im3:I (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX | BETA SHEET, BETA SANDWHICH, IMMUNOGLOBULIN (IG) FOLD, IMMUNOGLOBULIN (IG)-LIKE DOMAIN, PROTEIN COMPLEX, ALPHA HELIX, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
1im3:M (GLU212) to (TRP274) CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX | BETA SHEET, BETA SANDWHICH, IMMUNOGLOBULIN (IG) FOLD, IMMUNOGLOBULIN (IG)-LIKE DOMAIN, PROTEIN COMPLEX, ALPHA HELIX, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
1ind:L (GLY145) to (ALA212) HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB'(SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE | IMMUNOGLOBULIN
1ine:L (GLY145) to (ALA212) HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB'(SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE | IMMUNOGLOBULIN
2i9l:B (PRO155) to (PRO218) STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN | NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX
2i9l:F (PRO155) to (PRO218) STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN | NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX
2ial:B (HIS150) to (GLY237) STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED TCR | X-RAY CRYSTALLOGRAPHY, MAJOR HISTOCOMPATIBILITY COMPLEX, T CELL RECEPTOR, T CELL STIMULATION, MELANOMA, TUMOR ANTIGEN, IMMUNE SYSTEM
2ial:D (HIS150) to (GLY237) STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED TCR | X-RAY CRYSTALLOGRAPHY, MAJOR HISTOCOMPATIBILITY COMPLEX, T CELL RECEPTOR, T CELL STIMULATION, MELANOMA, TUMOR ANTIGEN, IMMUNE SYSTEM
2iam:D (HIS150) to (TRP236) STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED TCR | X-RAY CRYSTALLOGRAPHY, MAJOR HISTOCOMPATIBILITY COMPLEX, T CELL RECEPTOR, T CELL STIMULATION, MELANOMA, TUMOR ANTIGEN, IMMUNE SYSTEM
2ian:E (HIS150) to (ASP240) STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED TCR | X-RAY CRYSTALLOGRAPHY, MAJOR HISTOCOMPATIBILITY COMPLEX, T CELL RECEPTOR, T CELL STIMULATION, MELANOMA, TUMOR ANTIGEN, IMMUNE SYSTEM
2ian:J (HIS150) to (ASP240) STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED TCR | X-RAY CRYSTALLOGRAPHY, MAJOR HISTOCOMPATIBILITY COMPLEX, T CELL RECEPTOR, T CELL STIMULATION, MELANOMA, TUMOR ANTIGEN, IMMUNE SYSTEM
4may:D (HIS150) to (ASP240) CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX | IMMUNE COMPLEX, AUTOIMMUNITY, MULTIPLE SCLEROSIS, ANTIGEN PRESENTATION, IMMUNE SYSTEM
4mhh:J (PRO151) to (PRO227) CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1) | H5N1 INFLUENZA VIRUS, BROADLY NEUTRALIZING MURINE ANTIBODY, ESCAPE MUTANT, PASSIVE IMMUNOTHERAPY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3wjl:A (GLY271) to (LYS338) CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(V12), IN COMPLEX WITH FCGRIIB | RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM
3wkn:D (PRO271) to (LYS338) CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG | IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM
3wkn:I (ASP376) to (LEU443) CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG | IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM
5alb:L (GLY143) to (PRO209) TICAGRELOR ANTIDOTE CANDIDATE MEDI2452 IN COMPLEX WITH TICAGRELOR | IMMUNE SYSTEM, ANTIBODY FRAGMENT, ANTIDOTE, DRUG
1v7n:H (PRO152) to (VAL214) HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB | THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX
1v7n:I (PRO152) to (VAL214) HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB | THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX
1jck:A (HIS156) to (GLY243) T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN | T-CELL, RECEPTOR, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, ENTEROTOXIN, TOXIN, SUPERANTIGEN, COMPLEX (TOXIN/RECEPTOR)
1jck:C (HIS156) to (GLY243) T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN | T-CELL, RECEPTOR, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, ENTEROTOXIN, TOXIN, SUPERANTIGEN, COMPLEX (TOXIN/RECEPTOR)
4mnq:A (GLU212) to (TRP274) TCR-PEPTIDE SPECIFICITY OVERRIDES AFFINITY ENHANCING TCR-MHC INTERACTIONS | SURFACE PLASMON RESONANCE (SPR); BIACORETM; PEPTIDE-MAJOR HISTOCOMPATIBILITY COMPLEX (PMHC): T-CELL RECEPTOR (TCR), T-CELLS; HIGH AFFINITY TCR, TWO-STEP BINDING, ADOPTIVE THERAPY, IMMUNOGLOBULIN, ADAPTIVE IMMUNE RESPONSE, IMMUNE SYSTEM
4mnq:E (HIS151) to (TRP237) TCR-PEPTIDE SPECIFICITY OVERRIDES AFFINITY ENHANCING TCR-MHC INTERACTIONS | SURFACE PLASMON RESONANCE (SPR); BIACORETM; PEPTIDE-MAJOR HISTOCOMPATIBILITY COMPLEX (PMHC): T-CELL RECEPTOR (TCR), T-CELLS; HIGH AFFINITY TCR, TWO-STEP BINDING, ADOPTIVE THERAPY, IMMUNOGLOBULIN, ADAPTIVE IMMUNE RESPONSE, IMMUNE SYSTEM
5any:M (THR645) to (ARG708) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265 | VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB
5any:N (THR645) to (ARG708) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265 | VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB
5any:O (THR645) to (ARG708) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265 | VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB
5any:P (THR645) to (ARG708) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265 | VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB
1jnh:C (THR147) to (SER209) CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES | IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM
2j6e:A (PRO271) to (LYS338) CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION | AUTOIMMUNE COMPLEX HUMAN IGM RHEUMATOID FACTOR IGG1-FC, IMMUNOGLOBULIN C REGION, MEMBRANE, GLYCOPROTEIN, TRANSMEMBRANE, HYPOTHETICAL PROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN
4mvb:D (HIS151) to (TRP237) 42F3 PCPB7/H-2LD COMPLEX | IG, TCR, MHC, IMMUNE SYSTEM
1jvk:A (THR150) to (ALA212) THREE-DIMENSIONAL STRUCTURE OF AN IMMUNOGLOBULIN LIGHT CHAIN DIMER ACTING AS A LETHAL AMYLOID PRECURSOR | IMMUNOGLOBULIN LIGHT CHAIN DIMER, AMYLOIDOGENIC, IMMUNE SYSTEM
2xn9:B (HIS154) to (TRP240) CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN HUMAN T CELL RECEPTOR, STAPHYLOCOCCAL ENTEROTOXIN H AND HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II | IMMUNE SYSTEM, SUPERANTIGEN, IMMUNORECEPTORS, TERNARY COMPLEX
4n5e:D (HIS151) to (ALA240) 42F3 TCR PCPA12/H-2LD COMPLEX | IG, TCR, MHC, ANTIGEN, IMMUNE SYSTEM
1w72:M (GLY142) to (PRO211) CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3 | IMMUNE SYSTEM, HLA/FAB FRAGMENT, HUMAN LEUCOCYTE ANTIGEN, PEPTIDE-SPECIFIC FAB, TCR-LIKE BINDING, MHC-I
4n8c:H (PRO155) to (PRO218) THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS | ANTIBODY-PEPTIDE COMPLEX, INFLUENZA A VIRUS PROTEIN, IMMUNE SYSTEM
4n8c:I (PRO155) to (PRO218) THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS | ANTIBODY-PEPTIDE COMPLEX, INFLUENZA A VIRUS PROTEIN, IMMUNE SYSTEM
5brz:E (HIS153) to (ALA242) MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1 | IMMUNO PMHC TCR MAGE, IMMUNE SYSTEM
5bs0:E (HIS153) to (GLY240) MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1 | IMMUNO PMHC TCR TITIN, IMMUNE SYSTEM
4ndm:A (HIS156) to (TRP242) STRUCTURE OF THE AB18.1 TCR | IMMUNOGLOBULIN, HISTOCOMPATIBILITY ANTIGENS, T CELL RECEPTOR, IMMUNOLOGICAL, LYMPHOCYTES, T CELL RECOGNITION, ACTIVATION, GAMMA DELTA T CELL, HUMAN, INTRAEPITHELIAL LYMPHOCYTES, CD1D, GLYCOLIPIDS, NON-CLASSICAL MHC, GLYCOPROTEINS, CELL-SURFACE RECEPTORS, IMMUNE SYSTEM
2xzq:L (GLY145) to (ARG211) CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE YQLRPNAETLRF | BETA-SANDWICH IMMUNOGLOBULIN FOLD, ANTIGEN BINDING, SECRETED PROTEIN, IMMUNE SYSTEM
2y06:L (GLY145) to (ARG211) CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL | IMMUNE SYSTEM, BETA-SANDWICH IMMUNOGLOBULIN FOLD, ANTIGEN BINDING, SECRETED PROTEIN
2y07:L (THR148) to (SER210) CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI | IMMUNE SYSTEM, BETA-SANDWICH IMMUNOGLOBULIN FOLD, ANTIGEN BINDING, SECRETED PROTEIN
5bvj:H (PRO154) to (PRO218) THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA | IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM
5bw7:A (ASP376) to (LEU443) CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA | IMMUNE SYSTEM, COMPLEX, FC FRAGMENT, IGG, RECEPTOR, CD16, GAMMA
4nhu:B (HIS150) to (ALA239) THE M33 TCR P3M33L/H-2 LD COMPLEX | IG, TCR, MHC, ANTIGEN, IMMUNE SYSTEM
4nhu:D (HIS150) to (ALA239) THE M33 TCR P3M33L/H-2 LD COMPLEX | IG, TCR, MHC, ANTIGEN, IMMUNE SYSTEM
3zl4:L (GLY145) to (ALA210) ANTIBODY STRUCTURAL ORGANIZATION: ROLE OF KAPPA - LAMBDA CHAIN CONSTANT DOMAIN SWITCH IN CATALYTIC FUNCTIONALITY | IMMUNE SYSTEM
5c07:E (HIS156) to (TRP242) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c08:A (GLU212) to (TRP274) 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c08:J (HIS156) to (TRP242) 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0b:F (GLU212) to (TRP274) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI | IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM
5c09:A (GLU212) to (TRP274) HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c09:F (GLU212) to (TRP274) HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c09:J (HIS156) to (ALA245) HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0a:F (GLU212) to (TRP274) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0a:J (HIS156) to (ALA245) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
5c0c:A (GLU212) to (TRP274) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA | IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM
5c0c:F (GLU212) to (TRP274) 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA | IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM
5c0s:L (THR150) to (PRO213) CRYSTAL STRUCTURE OF A GENERATION 4 INFLUENZA HEMAGGLUTININ STABILIZED STEM IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODY CR6261 | HEMAGGLUTININ, IMMUNOGEN, TRIMER, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1ken:T (PRO156) to (LYS216) INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION | HEMAGGLUTININ, ENVELOPE PROTEIN, GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4nnx:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, POST TRANSLATIONAL MODIFICATION, TUMOR IMMUNOLOGY, TUMOR ANTIGENS, NEOEPITOPE, IMMUNE SYSTEM-ANTIGEN COMPLEX
1kj2:H (ASP212) to (TRP274) MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX | T CELL RECEPTOR, CLASS I MHC, H-2KB, TCR-PMHC COMPLEX, ALLOGENEIC, IMMUNE SYSTEM
4no2:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, PEPTIDE-MHC COMPLEX, MHC, TUMOR IMMUNOLOGY, PEPTIDE CONFORMATION, POST TRANSLATIONAL MODIFICATION, TUMOR ANTIGEN, NEOEPITOPE, IMMUNE SYSTEM-ANTIGEN COMPLEX
4no5:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF AMPD2 PHOSPHOPEPTIDE BOUND TO HLA-A2 | NONPHOSPHORYLATED PEPTIDE, PEPTIDE-MHC COMPLEX, MHC, PEPTIDE CONFORMATION, TUMOR IMMUNOLOGY, POST TRANSLATIONAL MODIFICATION, TUMOR ANTIGENS, IMMUNE SYSTEM-ANTIGEN COMPLEX
4nqc:E (HIS155) to (GLY242) CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL | MR1, T-CELL RECEPTOR, IMMUNE RECEPTOR COMPLEX, IG-FOLD, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM
4nqc:H (HIS155) to (GLY242) CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL | MR1, T-CELL RECEPTOR, IMMUNE RECEPTOR COMPLEX, IG-FOLD, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM
4nqd:E (HIS155) to (ALA244) CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL | IMMUNE COMPLEX, MR1, T-CELL RECEPTOR, IG-DOMAIN, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM
4nqd:H (HIS155) to (ALA244) CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL | IMMUNE COMPLEX, MR1, T-CELL RECEPTOR, IG-DOMAIN, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM
4nqe:E (HIS155) to (ALA244) CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL | IMMUNE COMPLEX, MR1, TCR, IG-DOMAIN, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM
2mcg:1 (GLY146) to (ALA211) THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS | IMMUNOGLOBULIN
1ktl:A (GLU212) to (TRP274) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E | HLA-E, MHC, NON-CLASSICAL MHC, HLA, BETA 2 MICROGLOBULIN, IMMUNE SYSTEM
1ktl:C (GLU212) to (TRP274) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E | HLA-E, MHC, NON-CLASSICAL MHC, HLA, BETA 2 MICROGLOBULIN, IMMUNE SYSTEM
1xcq:F (PRO154) to (PRO217) COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A,L57H,Y64W) IN SPACE GROUP P21 | CRYSTAL PACKING, FAB, PROTEIN L, PEPTIDE COMPLEX, IMMUNE SYSTEM
4nzt:L (THR145) to (ALA210) CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB | LEUCINE-RICH REPEAT, BROAD ANTIBODY-BINDING, BLOCK ANTIBODY-ANTIGEN UNION, VARIABLE REGION, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
2ypl:E (HIS150) to (TRP236) STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, MICROPOLYMORPHISM
5cey:C (THR146) to (ALA208) CRYSTAL STRUCTURE OF FAB 9H+3L, A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES | HIV-1, ANTIBODY, IMMUNE SYSTEM
4odv:L (ASP143) to (ASN212) FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE | CARBOHYDRATE BINDING, IMMUNE SYSTEM
1lgv:B (THR150) to (ALA212) STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 100K | HUMAN BENCE-JONES DIMER, MICROGRAVITY CRYSTALLIZATION, INDUCED FIT, IMMUNE SYSTEM
2z4q:B (PRO154) to (PRO217) CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528 | IMMUNE SYSTEM
1lo3:H (PRO155) to (LYS215) RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE | FAB, CATALYTIC ANTIBODY, PRODUCT COMPLEX, IMMUNE SYSTEM
4a6y:A (THR148) to (ARG211) CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 | IMMUNE SYSTEM, ANTIBODY MULTISPECIFICITY, HUMORAL IMMUNE SYSTEM, COMPLEMENTARITY DETERMINING REGION FLEXIBILITY
4a6y:L (THR148) to (ARG211) CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 | IMMUNE SYSTEM, ANTIBODY MULTISPECIFICITY, HUMORAL IMMUNE SYSTEM, COMPLEMENTARITY DETERMINING REGION FLEXIBILITY
2zjs:H (PRO155) to (LYS215) CRYSTAL STRUCTURE OF SECYE TRANSLOCON FROM THERMUS THERMOPHILUS WITH A FAB FRAGMENT | TRANSLOCON, SEC, PROTEIN-CONDUCTING-CHANNEL, MEMBRANE, PROTEIN TRANSPORT, TRANSLOCATION, TRANSMEMBRANE, TRANSPORT, PROTEIN TRANSPORT-IMMUNE SYSTEM COMPLEX
2zpk:L (THR146) to (ALA210) CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE | MOUSE IGG FAB FRAGMENT IN COMPLEX WITH ANTIGEN PEPTIDE, IMMUNE SYSTEM
2zpk:M (THR146) to (SER208) CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE | MOUSE IGG FAB FRAGMENT IN COMPLEX WITH ANTIGEN PEPTIDE, IMMUNE SYSTEM
1mcd:A (THR149) to (PRO212) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN
1mci:A (ALA147) to (ALA211) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN, IMMUNE SYSTEM
1mcj:B (THR149) to (ALA211) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN
1mcl:B (THR149) to (PRO212) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN, IMMUNE SYSTEM
1mcq:A (ALA147) to (PRO212) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN
1mfb:L (THR148) to (SER210) HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA | IMMUNOGLOBULIN
4ozh:H (HIS167) to (TRP253) S16 PROTEIN COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
1mi5:E (HIS157) to (TRP243) THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX | T CELL RECEPTOR, MAJOR HISTOCOMPATABILITY COMPLEX (CLASS I), HLA B8, EPSTEIN BARR VIRUS, IMMUNODOMINANT TCR (LC13), IMMUNE SYSTEM
5d2n:F (HIS156) to (TRP242) CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX | TCR, NLV, HLA-A2, IMMUNE SYSTEM
5d2n:H (GLU212) to (TRP274) CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX | TCR, NLV, HLA-A2, IMMUNE SYSTEM
5d2n:E (HIS156) to (ALA245) CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX | TCR, NLV, HLA-A2, IMMUNE SYSTEM
3kr3:H (PRO158) to (PRO222) CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX | ANTIBODY-TARGET COMPLEX, CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, GLYCOPROTEIN, GROWTH FACTOR, HORMONE, MITOGEN, OSTEOGENESIS, SECRETED, IMMUNE SYSTEM
5d7l:H (VAL154) to (TRP239) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR | RECEPTOR, ANTIGEN, IMMUNE SYSTEM
5d9q:E (THR146) to (PRO209) CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46 | HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM
5d9q:M (THR146) to (PRO209) CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46 | HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM
5d9s:A (GLU212) to (TRP274) STRUCTURE OF HLA-A2:01 WITH THE 11-MER PEPTIDE F11V | PEPTIDE COMPLEX, MHC, IMMUNE SYSTEM
3kym:D (PRO155) to (PRO208) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
5di8:B (PRO271) to (LYS338) FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V | HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM
4pj8:D (HIS156) to (GLY243) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pjc:F (HIS154) to (GLY241) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pjc:H (HIS154) to (GLY241) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pje:F (HIS153) to (ALA242) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pjg:F (HIS154) to (ALA243) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pjh:F (HIS152) to (ALA241) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
4pjh:H (HIS152) to (ALA241) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
5dj0:B (PRO271) to (LYS338) FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q | HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM
4pjx:H (HIS154) to (ALA243) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR | MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM
5djy:B (PRO271) to (LYS338) FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A | HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM
1yyl:R (PRO1149) to (PRO1213) CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M33, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3l7f:B (PRO157) to (PRO221) STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4amk:L (THR148) to (ARG211) FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10 | IMMUNE SYSTEM, 13G10, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE
3ld8:C (PRO156) to (LYS216) STRUCTURE OF JMJD6 AND FAB FRAGMENTS | JMJD6, FAB FRAGMENTS, IMMUNE SYSTEM
4ptt:B (PRO149) to (PRO213) CRYSTAL STRUCTURE OF ANTI-23F STREP FAB C05 | ANTIBODY, FAB FRAGMENT, 23F, RHAMNOSE, IMMUNE SYSTEM
1za6:F (PRO151) to (PRO215) THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY | IMMUNOGLOBULIN FOLD, CH2-DOMAIN-DELETION, IMMUNE SYSTEM
5dr5:H (PRO151) to (PRO215) CRYSTAL STRUCTURE OF THE SCLEROSTIN-NEUTRALIZING FAB ABD09097 | SCLEROSTIN-NEUTRALIZING, FAB, WNT INHIBITOR, IMMUNE SYSTEM
4apq:D (HIS157) to (GLY244) CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE | IMMUNITY, APC CELL SURFACE, IMMUNE SYSTEM
1zgl:P (HIS157) to (GLY244) CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A | TCR/PEPTIDE/MHC COMPLEX, IMMUNE SYSTEM
1zgl:R (HIS157) to (ALA240) CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A | TCR/PEPTIDE/MHC COMPLEX, IMMUNE SYSTEM
4at6:B (THR148) to (ARG211) FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7 | IMMUNE SYSTEM, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE
4at6:D (THR148) to (ARG211) FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7 | IMMUNE SYSTEM, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE
4at6:F (THR148) to (ARG211) FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7 | IMMUNE SYSTEM, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE
4at6:I (THR148) to (ARG211) FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7 | IMMUNE SYSTEM, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE
4at6:K (THR148) to (ARG211) FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7 | IMMUNE SYSTEM, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE
4at6:L (THR148) to (ARG211) FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7 | IMMUNE SYSTEM, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE
3arb:D (HIS157) to (ALA246) TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH | MOUSE NKT TCR, MOUSE CD1D, IMMUNE SYSTEM
3arf:D (HIS157) to (GLY244) TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2 | MOUSE CD1D, MOUSE NKT TCR, IMMUNE SYSTEM
3arg:D (HIS157) to (ALA246) TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA- GLUCOSYLCERAMIDE(C20:2) | MOUSE NKT TCR, MOUSE CD1D, IMMUNE SYSTEM
5e6i:Q (GLU154) to (GLY239) CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2 | IMMUNE SYSTEM, TCR, HLA-A2, FLU, COMPLEX
4q7d:A (ASP376) to (LEU443) WILD TYPE FC (WTFC) | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4q97:A (ASN174) to (SER241) IGNAR ANTIBODY DOMAIN C1 | PROTEIN EVOLUTION, ANTIBODY STRUCTURE, PROTEIN FOLDING, IMMUNE SYSTEM
4q97:B (ASN174) to (SER241) IGNAR ANTIBODY DOMAIN C1 | PROTEIN EVOLUTION, ANTIBODY STRUCTURE, PROTEIN FOLDING, IMMUNE SYSTEM
4qci:L (THR143) to (PRO205) PDGF-B BLOCKING ANTIBODY BOUND TO PDGF-BB | GROWTH FACTOR CYTOKINE FOLD, GROWTH FACTOR HORMONE, PDGFR-BETA RECEPTOR, EXTRACELLULAR, CYTOKINE-CYTOKINE RECEPTOR COMPLEX
3ay4:A (ILE377) to (LEU443) CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA | IMMUNE SYSTEM, COMPLEX, FC FRAGMENT, IGG, RECEPTOR, CD16, GAMMA
4qhk:N (THR145) to (PRO208) UCA (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
4qhk:L (THR145) to (PRO208) UCA (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
4qhm:F (GLY142) to (PRO208) I3.1 (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
3mbe:D (HIS167) to (ALA252) TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27) | T CELL RECEPTOR, HISTOCOMPATABILITY ANTIGEN, MHC CLASS II, I-AG7, IMMUNE SYSTEM
4qok:E (ASP153) to (GLY241) STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES | IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM
3mj8:A (ALA145) to (PRO211) CRYSTAL STRUCTURE OF HL4E10 FAB, A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS | ANTIBODY, HAMSTER IGG, IMMUNE SYSTEM
3mj9:L (ASP143) to (PRO211) CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10 | IMMUNOGLOBULIN TANDEM DOMAIN, RECEPTOR-ANTIBODY COMPLEX, CELL ADHESION, CELL JUNCTION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, COSTIMULATION, HAMSTER IGG, TRANSMEMBRANE, IMMUNE SYSTEM
3mlt:D (GLY146) to (PRO212) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mlu:L (GLY146) to (PRO212) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A ZAM18 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mlw:L (THR145) to (PRO208) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
4qrp:E (HIS167) to (GLY254) CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR | HLA B*0801, HUAMN HEPATITIS C VIRUS, TCR, T CELL, IMMUNE SYSTEM
4qrp:L (HIS167) to (GLY254) CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR | HLA B*0801, HUAMN HEPATITIS C VIRUS, TCR, T CELL, IMMUNE SYSTEM
3bgm:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, HLA-A2, ANCHOR RESIDUE, TUMOR ANTIGEN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNOGLOBULIN DOMAIN, KINASE, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, IMMUNE SYSTEM
5euo:A (GLU212) to (TRP274) PF6-M1-HLA-A2 | TCR, FLU, MHC, IMMUNE SYSTEM
5euo:F (HIS150) to (ALA239) PF6-M1-HLA-A2 | TCR, FLU, MHC, IMMUNE SYSTEM
3mrg:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN
3mrl:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE C6V VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN
3mrm:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1406-1415 DECAPEPTIDE | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN
3mrp:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, TUMORAL PEPTIDE, MELAN-A, MART1
3bjl:B (ALA147) to (PRO212) LOC, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN AMMONIUM SULFATE | BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES, IMMUNOGLOBULIN
3bkc:H (PRO149) to (LYS209) CRYSTAL STRUCTURE OF ANTI-AMYLOID BETA FAB WO2 (P21, FORMB) | ABETA, AMYLOID BETA PEPTIDE, FAB, WO2, ALZHEIMER'S DISEASE, IMMUNOTHERAPIES, APP, IMMUNE SYSTEM
3mug:A (GLY142) to (ALA210) CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | PG16, FAB, SULFOTYROSINE, HIV, IMMUNE SYSTEM
3mug:E (THR145) to (PRO211) CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | PG16, FAB, SULFOTYROSINE, HIV, IMMUNE SYSTEM
3mug:G (GLY142) to (ALA210) CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | PG16, FAB, SULFOTYROSINE, HIV, IMMUNE SYSTEM
3mug:I (GLY142) to (ALA210) CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | PG16, FAB, SULFOTYROSINE, HIV, IMMUNE SYSTEM
3mug:K (THR145) to (PRO211) CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | PG16, FAB, SULFOTYROSINE, HIV, IMMUNE SYSTEM
4bsw:B (ASP376) to (LEU443) HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 | IMMUNE SYSTEM, BISPECIFIC, SCAFFOLD, ANTIBODY ENGINEERING, FC DOMAIN, IGG, IGG1, IMMUNOGLOBULIN G, ZYMEWORKS INC.
3bze:C (GLU212) to (TRP274) THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- E | MHC FOLD, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3c2a:L (GLY142) to (ALA210) ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE | ANTIBODY FAB HIV-1 PEPTIDE, ENVELOPE PROTEIN, IMMUNE SYSTEM
3c2s:A (PRO271) to (LYS338) STRUCTURAL CHARACTERIZATION OF A HUMAN FC FRAGMENT ENGINEERED FOR LACK OF EFFECTOR FUNCTIONS | FC FRAGMENT, MUTANT, EFFECTOR FUNCTION, RECEPTOR, PROTEIN BINDING, IMMUNE SYSTEM
5fhc:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP) | IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, EBOLA VIRUS, GLYCOPROTEIN, GP, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3n9g:L (GLY150) to (PRO216) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI- WEST NILE VIRUS MAB CR4354 | FAB FRAGMENT, HUMAN NEUTRALIZING ANTIBODY, MAB CR4354, IMMUNE SYSTEM, ANTI-WEST NILE VIRUS
5fka:B (HIS153) to (ALA242) CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN E IN COMPLEX WITH A T CELL RECEPTOR | IMMUNE SYSTEM, SUPERANTIGEN, STAPHYLCOCOCCAL ENTEROTOXIN, T CELL RECEPTOR, MAJOR HISTOCOMPATIBILITY COMPLEX
3ncy:P (PRO156) to (PRO219) X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT | MEMBRANE PROTEIN COMPLEX WITH FAB FRAGMENT, ARGININE AGMATINE ANTIPORTER, VIRTUAL PROTON PUMP, APC SUPERFAMILY, IMMUNE SYSTEM, TRANSPORT PROTEIN
3cfj:F (PRO151) to (PRO227) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
4rfe:L (GLY142) to (PRO208) CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB | HIV-1 GP120 SPECIFIC ANTIBODY, CD4I ANTIBODY, ADCC, HIV-1 ENV, ANTI- HIV-1 ENV ANTIBODY JR4, IMMUNE SYSTEM
4rfe:B (GLY142) to (PRO208) CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB | HIV-1 GP120 SPECIFIC ANTIBODY, CD4I ANTIBODY, ADCC, HIV-1 ENV, ANTI- HIV-1 ENV ANTIBODY JR4, IMMUNE SYSTEM
4rfn:L (GLY142) to (ALA207) CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48 | HIV-1 GP120, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3nif:H (PRO155) to (PRO218) THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING | INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-BLOOD CLOTTING COMPLEX
3cmo:H (PRO149) to (PRO223) HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18 | HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3cmo:Y (VAL150) to (PRO223) HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18 | HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3o6f:D (HIS154) to (ALA243) CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4 | AUTOIMMUNITY, MULTIPLE SCLEROSIS, T CELL RECEPTOR, HLA CLASS II, PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN FOLD, MEMBRANE, IMMUNE SYSTEM
3o8x:D (HIS151) to (TRP237) RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
3o9w:D (HIS151) to (TRP237) RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
3d69:A (SER154) to (PRO209) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-FACTOR IX ANTIBODY 10C12 | ANTICOAGULANT, 10C12, FACTOR IX, GLA DOMAIN, IMMUNE SYSTEM
4tnv:N (GLY145) to (ARG211) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnv:O (GLY145) to (ARG211) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnv:f (GLY145) to (CYS214) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnv:h (VAL146) to (ARG211) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnv:i (GLY145) to (CYS214) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnv:M (VAL146) to (ARG211) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnw:L (THR148) to (ARG211) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnw:O (GLY145) to (ARG211) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnw:Z (THR148) to (ARG211) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnw:f (THR148) to (SER210) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnw:g (THR148) to (ARG211) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnw:h (VAL146) to (ARG211) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnw:i (THR148) to (ARG211) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4tnw:M (VAL146) to (SER208) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
5ghw:L (THR146) to (PRO209) CRYSTAL STRUCTURE OF BROAD NEUTRALIZING ANTIBODY 10E8 WITH LONG EPITOPE BOUND | BROAD NEUTRALIZING ANTIBODY, RECOMBINANT FAB, EPITOPE, IMMUNE SYSTEM, HIV-1, VIRAL MEMBRANE
5gir:H (PRO149) to (LYS209) CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE | FAB, PEPTIDE LIGAND, MUTATION, IMMUNE SYSTEM
4d2n:B (PRO271) to (LYS338) CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC | IMMUNE SYSTEM, IGG, IMMUNOGLOBULIN, IGG1
4tvp:L (THR146) to (PRO209) CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 | HIV-1 ENVELOPE TRIMER, GP120, GP41, MEMBRANE FUSION, VIRAL ENTRY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, TYPE-1 MEMBRANE FUSION GLYCOPROTEIN
3dnk:A (LYS274) to (LYS338) ENZYME DEGLYCOSYLATED HUMAN IGG1 FC FRAGMENT | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3dnk:B (LYS1274) to (LYS1338) ENZYME DEGLYCOSYLATED HUMAN IGG1 FC FRAGMENT | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3dnk:B (ASP1376) to (LEU1443) ENZYME DEGLYCOSYLATED HUMAN IGG1 FC FRAGMENT | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4u1g:E (PRO158) to (PRO221) PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY QA1 | MALARIA ERYTHROCYTE INVASION ANTIBODY-MEDIATED INHIBITION, IMMUNE SYSTEM
4u1i:A (GLU212) to (TRP274) HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES | IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM
5hdb:H (PRO155) to (LYS215) INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054 | CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX, INTEGRIN INHIBITOR, RGD MIMETICS
3ox8:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27 | PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM
3oxr:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA A*02:06 BOUND TO HBV CORE 18-27 | PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM
5hhn:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-F5L | HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM
5hhq:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-L3W | HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM
5hhv:L (ALA144) to (ALA208) INHIBITING COMPLEX IL-17A AND IL-17RA INTERACTIONS WITH A LINEAR PEPTIDE | IL-17, INFLAMMATION, INHIBITOR, COMPLEX CRYSTAL STRUCTURE, IMMUNE SYSTEM-INHIBITOR COMPLEX
5hi3:D (ALA144) to (ALA208) BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS | IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX
5hi3:L (THR146) to (PRO209) BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS | IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX
4ubd:C (PRO162) to (PRO226) CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA | HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ubd:Y (PRO162) to (PRO226) CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA | HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ubd:G (PRO162) to (PRO226) CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA | HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ubd:S (PRO162) to (PRO226) CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA | HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ubd:O (PRO162) to (PRO226) CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA | HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ubd:K (PRO162) to (PRO226) CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA | HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3pab:A (ASP212) to (TRP274) CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-E1 | H2KB, OVA, APL, ALTERED PEPTIDE LIGANDS, OVALBUMIN, TCR, T CELL, IMMUNE SYSTEM
4udt:B (HIS153) to (ALA242) T CELL RECEPTOR (TRAV22,TRBV7-9) STRUCTURE | IMMUNE SYSTEM, SUPERANTIGEN, STAPHYLCOCOCCAL ENTEROTOXIN, T CELL RECEPTOR, MAJOR HISTOCOMPATIBILITY COMPLEX
5i1l:B (PRO155) to (PRO219) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i2i:B (PRO155) to (PRO219) STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE | IMMUNE SYSTEM, ANTIBODY
4uim:H (PRO158) to (PRO221) CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3 | IMMUNE SYSTEM, QUININE-DEPENDENT, MOUSE MAB
3pl6:D (HIS177) to (ASP267) STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99 | TCR-MHC COMPLEX, IMMUNOGLOBULIN FOLD, IMMUNE RECEPTOR, MEMBRANE, IMMUNE SYSTEM
4dzb:B (HIS156) to (ALA245) MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR, VALPHA7.2JALPHA33-VBETA2 | MAIT T CELL RECEPTOR, IMMUNE SYSTEM
4e42:B (VAL150) to (TRP235) STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4 | IG DOMAIN, ADAPTIVE IMMUNITY, T CELL RECEPTOR, MHC, IMMUNE SYSTEM
4e42:D (VAL150) to (ALA238) STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4 | IG DOMAIN, ADAPTIVE IMMUNITY, T CELL RECEPTOR, MHC, IMMUNE SYSTEM
5ihu:L (GLY142) to (LYS207) CRYSTAL STRUCTURE OF BOVINE FAB B11 | ANTIBODY FAB ULTRALONG CDRH3, IMMUNE SYSTEM
5ijv:L (GLY142) to (LYS207) CRYSTAL STRUCTURE OF BOVINE FAB E03 | ANTIBODY FAB ULTRALONG CDR H3, IMMUNE SYSTEM
5ijv:A (GLY142) to (LYS207) CRYSTAL STRUCTURE OF BOVINE FAB E03 | ANTIBODY FAB ULTRALONG CDR H3, IMMUNE SYSTEM
5ijv:E (GLY142) to (LYS207) CRYSTAL STRUCTURE OF BOVINE FAB E03 | ANTIBODY FAB ULTRALONG CDR H3, IMMUNE SYSTEM
4en3:B (HIS156) to (TRP242) CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE | IMMUNOGLOBULIN-LIKE, MHC CLASS I-LIKE, ANTIGEN PRESENTATION- RECOGNITION, MEMBRANE, IMMUNE SYSTEM
5itb:H (PRO164) to (PRO228) CRYSTAL STRUCTURE OF THE ANTI-RSV F FAB 14N4 | ANTIBODY, IMMUNE SYSTEM
3q6g:L (GLY142) to (PRO208) CRYSTAL STRUCTURE OF FAB OF RHESUS MAB 2.5B SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120 | IG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM
3qdm:A (GLU212) to (TRP274) THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE | MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM
3qh3:B (HIS155) to (ALA244) THE CRYSTAL STRUCTURE OF TCR A6 | TAX PEPTIDE, TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, IMMUNE SYSTEM
3qhz:L (GLY142) to (SER215) CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1 | IMMUNOGLOBULIN, IMMUNE RECOGNITION, INFLUENZA A HEMAGGLUTININ, IMMUNE SYSTEM
3qi9:D (HIS157) to (TRP243) CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR | AUTOREACTIVITY, T-CELL SURFACE, IMMUNE SYSTEM
3qjf:B (HIS154) to (ALA243) CRYSTAL STRUCTURE OF THE 2B4 TCR | IMMUNOGLOBULIN DOMAIN, T CELL RECEPTOR, IMMUNE SYSTEM
3qjf:D (HIS154) to (ALA243) CRYSTAL STRUCTURE OF THE 2B4 TCR | IMMUNOGLOBULIN DOMAIN, T CELL RECEPTOR, IMMUNE SYSTEM
3qjh:B (HIS157) to (TRP243) THE CRYSTAL STRUCTURE OF THE 5C.C7 TCR | IMMUNOGLOBULIN DOMAIN, T CELL RECEPTOR, IMMUNE SYSTEM
3qjh:D (HIS157) to (ALA246) THE CRYSTAL STRUCTURE OF THE 5C.C7 TCR | IMMUNOGLOBULIN DOMAIN, T CELL RECEPTOR, IMMUNE SYSTEM
3qpq:H (PRO155) to (HIS219) CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3
3qpq:F (PRO155) to (HIS218) CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3
3qrg:H (PRO156) to (PRO220) CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M | FAB STRUCTURE, RSV, IMMUNE SYSTEM
3qum:H (SER149) to (ILE210) CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY | KALLIKREIN FOLD, PROSTATE-SPECIFIC ANTIGEN, SERINE PROTEASE, NEGATIVE REGULATION OF ANGIOGENESIS, NATURAL POST-TRANSDUCTIONAL MODIFICATION, N-LINKED AND O-LINKED GLYCOSYLATION, IMMUNE SYSTEM
3qum:D (SER150) to (VAL212) CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY | KALLIKREIN FOLD, PROSTATE-SPECIFIC ANTIGEN, SERINE PROTEASE, NEGATIVE REGULATION OF ANGIOGENESIS, NATURAL POST-TRANSDUCTIONAL MODIFICATION, N-LINKED AND O-LINKED GLYCOSYLATION, IMMUNE SYSTEM
3qux:D (HIS151) to (ALA240) STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
4w4n:B (ASP376) to (LEU443) CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A | HUMAN FC ASYMMETRY DYNAMICS IMMUNE MOLECULE, IMMUNE SYSTEM
3rev:B (HIS153) to (TRP239) CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20 | T CELL RECEPTOR, MHC CLASS I, TUMOUR ANTIGEN, IMMUNE SYSTEM, IMMUNE RESPONSE, ALLOREACTIVITY, IMMUNOGLOBULIN DOMAIN
4fqj:L (GLY142) to (ALA207) INFLUENZA B/FLORIDA/4/2006 HEMAGGLUTININ FAB CR8071 COMPLEX | MONOCLONAL, IMMUNOGLOBULIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fqk:F (GLY142) to (ALA207) INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX | ANTIBODY, FAB FRAGMENT, MONOCLONAL, IMMUNOGLOBULIN, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
4fqk:L (GLY142) to (ALA207) INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX | ANTIBODY, FAB FRAGMENT, MONOCLONAL, IMMUNOGLOBULIN, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
4g8f:B (HIS166) to (ALA255) CRYSTAL STRUCTURE OF CLONE42 TCR | TCR, T CELL, CD1B, GMM, LIPID RECOGNITION, IMMUNE SYSTEM
4gg6:F (HIS167) to (TRP253) PROTEIN COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4gg6:H (HIS167) to (TRP253) PROTEIN COMPLEX | IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM
4gg8:F (HIS155) to (TRP241) IMMUNE RECEPTOR | IMMUNE RECEPTOR, IMMUNE SYSTEM
4gg8:B (HIS155) to (TRP241) IMMUNE RECEPTOR | IMMUNE RECEPTOR, IMMUNE SYSTEM
5kjr:L (THR145) to (PRO208) CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 W69A/S115W MUTANT AND M48U1. | HIV-1 GP120, CLADE A/E 93TH057, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX
4glr:I (GLY142) to (ALA207) STRUCTURE OF THE ANTI-PTAU FAB (PT231/PS235_1) IN COMPLEX WITH PHOSPHOEPITOPE PT231/PS235 | IGG1 FAB, ANTI-PTAU ANTIBODY, PHOSPHORYLATED TAU PEPTIDE, PHOSPHORYLATION, IMMUNE SYSTEM
4gmt:I (PRO149) to (PRO212) CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 | FAB, FRAGMENT ANTIGEN BINDING, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
5ks9:F (HIS167) to (ALA256) BEL502-DQ8-GLIA-ALPHA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5ks9:H (HIS167) to (GLY254) BEL502-DQ8-GLIA-ALPHA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5ksa:D (HIS167) to (ALA256) BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5ksb:F (HIS167) to (ALA256) T15-DQ8.5-GLIA-GAMMA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5ksb:H (HIS167) to (ALA256) T15-DQ8.5-GLIA-GAMMA1 COMPLEX | CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM
5l2k:E (HIS166) to (GLY253) CRYSTAL STRUCTURE OF GEM42 TCR-CD1B-GMM COMPLEX | CD1B, LIPID, TB, MTB, GMM, TUBERCULOSIS, GEM T CELL, TCR, T CELL, GEM42, IMMUNE SYSTEM
7fab:L (GLY138) to (PRO204) CRYSTAL STRUCTURE OF HUMAN IMMUNOGLOBULIN FRAGMENT FAB NEW REFINED AT 2.0 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN, IMMUNE SYSTEM
2ak4:E (HIS157) to (TRP243) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE | T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM
2ak4:J (HIS157) to (TRP243) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE | T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM
2ak4:P (HIS157) to (TRP243) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE | T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM
2ak4:U (HIS157) to (TRP243) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE | T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM
1nfd:B (HIS156) to (GLY243) AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY | COMPLEX (IMMUNORECEPTOR-IMMUNOGLOBULIN), COMPLEX (IMMUNORECEPTOR- IMMUNOGLOBULIN) COMPLEX
1nfd:D (HIS156) to (GLY243) AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY | COMPLEX (IMMUNORECEPTOR-IMMUNOGLOBULIN), COMPLEX (IMMUNORECEPTOR- IMMUNOGLOBULIN) COMPLEX
4wi3:A (GLU272) to (LYS338) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
4wi3:B (GLU272) to (LYS338) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
4wi6:A (PRO271) to (LYS338) STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A | HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
3rwc:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW9 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
3rwc:D (GLU212) to (TRP274) CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW9 | ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM
1aqk:L (THR149) to (PRO212) THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR TETANUS TOXOID | HUMAN FAB, ANTI-TETANUS TOXOID, HIGH AFFINITY, CRYSTAL PACKING MOTIF, PROGRAMMING PROPENSITY TO CRYSTALLIZE, IMMUNOGLOBULIN
4x4m:A (ILE377) to (SER442) STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING | IMMUNE SYSTEM
4x4m:B (ILE377) to (LEU443) STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING | IMMUNE SYSTEM
4x4m:D (ILE377) to (SER444) STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING | IMMUNE SYSTEM
2bnr:E (HIS152) to (ALA241) STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES | IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR, SUPERAGONIST PEPTIDE T-CELL VACCINES
2bnu:B (HIS152) to (ALA241) STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES | SUPERAGONIST PEPTIDE T-CELL VACCINES, RECEPTOR, T-CELL, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM/RECEPTOR
2pyf:B (HIS151) to (ASP241) CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1 | T-CELL RECEPTOR, CDR3, PHAGE DISPLAY, MUTANT, HIGH AFFINITY, NY-ESO- 1, IMMUNE SYSTEM
1pg7:Y (ARG146) to (SER206) MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB | IMMUNE SYSTEM
1dqm:H (PRO149) to (LYS220) CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY | ANTIBODY, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM
3gjf:A (GLU212) to (TRP274) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3gjf:K (GLY145) to (ALA210) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
1q0x:L (THR145) to (SER210) ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM | ANTI-MORPHINE ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
4jan:B (GLY142) to (PRO208) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120 | HIV-1, GP120, GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, ANTIBODY, IMMUNOGLOBULIN, NEUTRALIZATION, VACCINE
4jrx:E (HIS163) to (ALA252) CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX | TCR, T CELL, HLA B*3508, LPEP, EBV, ALLOREACTIVITY, IMMUNE SYSTEM
1qrn:E (HIS156) to (ALA245) CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A | HUMAN TCR/PEPTIDE/MHC COMPLEX, HLA-A2, HTLV-1, TAX, TCR, T CELL RECEPTOR, IMMUNE SYSTEM
4yny:B (ASP165) to (PRO229) CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 | ANTIBODIES, MONOCLONAL, ANTIBODY AFFINITY, CHROMATOGRAPHY, AFFINITY, EPITOPES, RATS, IMMUNOGLOBULIN FAB FRAGMENTS, KINETICS, PROTEIN BINDING, PROTEINS, RECOMBINANT FUSION PROTEINS, HUMAN PODOPLANIN, IMMUNE SYSTEM
4k8r:L (THR150) to (ALA212) AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO | IMMUNOGLOBULIN, IMMUNE SYSTEM
1rjy:A (ASP212) to (TRP274) MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE | MHC, CLASS I, PEPTIDE, VIRUS, TCR, HERPES, IMMUNE SYSTEM
2vdr:H (PRO155) to (LYS215) INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, LGGAKQRGDV | CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, PLATELET INTEGRIN ALPHAIIBBETA3, GLYCOPROTEIN, CELL ADHESION, MEMBRANE, INTEGRIN, RECEPTOR, ANTAGONIST, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, CELL ADHESION/IMMUNE SYSTEM COMPLEX
3v4v:M (PRO157) to (VAL219) CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376 | CELL ADHESION, MADCAM-1, MEMBRANE
2vuo:B (ILE377) to (ARG443) CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT | IMMUNE SYSTEM, IMMUNOGLOBULIN C REGION, IGG, RABBIT, FC FRAGMENT, GLYCOSYLATION, IMMUNOGLOBULINS, IMMUNOGLOBULIN DOMAIN
3i9g:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE | ANTIBODY, FAB, SPHINGOSINE-1-PHOSPHATE, CALCIUM, IMMUNOGLOBIN, IGG, IMMUNE SYSTEM
2wah:A (PRO271) to (LYS338) CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2) | IMMUNOGLOBULIN C REGION, ANTIBODY ENGINEERING, IMMUNOGLOBULIN DOMAIN, SECRETED, ANTIBODY, KIFUNENSINE, GLYCOPROTEIN, OLIGOMANNOSE, IMMUNE SYSTEM, GLYCOSYLATION
2wbj:D (HIS180) to (TRP266) TCR COMPLEX | TRANSMEMBRANE, IMMUNE RESPONSE, T CELL RECEPTOR, MHC II, MEMBRANE, RECEPTOR, MOLECULAR MIMICRY, MULTIPLE SCLEROSIS, IMMUNE SYSTEM, AUTOIMMUNITY, GLYCOPROTEIN, MHC CLASS II
2wbj:H (HIS180) to (TRP266) TCR COMPLEX | TRANSMEMBRANE, IMMUNE RESPONSE, T CELL RECEPTOR, MHC II, MEMBRANE, RECEPTOR, MOLECULAR MIMICRY, MULTIPLE SCLEROSIS, IMMUNE SYSTEM, AUTOIMMUNITY, GLYCOPROTEIN, MHC CLASS II
3vxq:E (HIS153) to (ASP243) H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10 | HIV-1, NEF, IMMUNE SYSTEM, T CELL RECEPTOR, IMMUNOGLOBURIN DOMAIN, TCR, IMMUNE RESPONSE
1j8h:E (HIS157) to (ALA246) CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR4 | PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4nki:L (ALA147) to (ALA211) CRYSTAL STRUCTURE OF A FAB | NONOCLONAL ANTIBODY, IMMUNOGLOBULIN, ANTIBODY, PD-L1, SOLUBLE PROTEIN, CYTOKINE
4no3:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF AMPD2 PHOSPHOPEPTIDE BOUND TO HLA-A2 | PHOSPHOSERINE, PHOSPHOPEPTIDE, PEPTIDE-MHC COMPLEX, MHC, TUMOR IMMUNOLOGY, PEPTIDE CONFORMATION, POST TRANSLATIONAL MODIFICATION, TUMOR ANTIGEN, NEOEPITOPE, IMMUNE SYSTEM-ANTIGEN COMPLEX
1l7i:H (PRO149) to (PRO213) CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4 | IG DOMAIN, FAB FRAGMENT, IMMUNE SYSTEM
5cez:L (THR146) to (PRO209) CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM | HIV-1, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1mcc:A (ALA147) to (PRO212) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN, IMMUNE SYSTEM
1mfe:L (THR148) to (ARG211) RECOGNITION OF A CELL-SURFACE OLIGO-SACCHARIDE OF PATHOGENIC SALMONELLA BY AN ANTIBODY FAB FRAGMENT | IMMUNOGLOBULIN
1mfd:L (THR148) to (SER210) THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE | IMMUNOGLOBULIN
4p2q:T (HIS154) to (TRP240) CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK | T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM
5d7k:E (HIS153) to (ALA242) STRUCTURE OF MR1-REACTIVE MAV36 TCR | RECEPTOR, ANTIGEN, IMMUNE SYSTEM
3kxf:O (HIS153) to (TRP239) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER | MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
5dfv:C (PRO1035) to (PRO1098) CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04 | HELICAL BUNDLE, CELL ADHESION, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
4pj5:E (HIS155) to (ALA244) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR | MR1, MAIT TCR, AC-6-FP, IMMUNE COMPLEX, IMMUNE SYSTEM
4pj5:H (HIS155) to (ALA244) STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR | MR1, MAIT TCR, AC-6-FP, IMMUNE COMPLEX, IMMUNE SYSTEM
4pja:F (HIS153) to (GLU237) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
4pja:H (HIS153) to (GLY240) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR | MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM
5djc:E (ASP376) to (LEU443) FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F | HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM
4prp:E (HIS164) to (GLY251) CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:01-HPVG-Q5 COMPLEX | HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM
5e99:L (GLY142) to (LYS207) BOVINE FAB FRAGMENT F08_B11 | ANTIBODY, FAB BOVINE, IMMUNE SYSTEM
3axl:B (HIS167) to (ALA256) MURINE VALPHA 10 VBETA 8.1 T-CELL RECEPTOR | IMMUNOGLOBULIN FOLD, T-CELL RECEPTOR, CD1D BINDING, IMMUNE SYSTEM
3axl:H (HIS167) to (ALA256) MURINE VALPHA 10 VBETA 8.1 T-CELL RECEPTOR | IMMUNOGLOBULIN FOLD, T-CELL RECEPTOR, CD1D BINDING, IMMUNE SYSTEM
3mac:L (THR147) to (PRO210) CRYSTAL STRUCTURE OF GP41-DERIVED PROTEIN COMPLEXED WITH FAB 8062 | GP41, FAB8062, IMMUNE SYSTEM
5eu6:A (GLU212) to (TRP274) HLA CLASS I ANTIGEN | IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM
3mrc:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6C VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, CYTOMEGALOVIRUS, PP65 PROTEIN
3mro:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT | MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, TUMORAL PEPTIDE, MELAN-A, MART1
3c6l:B (HIS150) to (GLU211) CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR 2W20 | TCR-PMHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC II, TRANSMEMBRANE, SUGAR BINDING PROTEIN/IMMUNE SYSTEM COMPLEX
3d39:E (HIS156) to (ALA245) THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE | HTLV-1 TAX PEPTIDE, 4-FLUOROPHENYLALANINE, MHC CLASS I, HLA-A2, T- CELL RECEPTOR A6, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
4ttd:D (THR146) to (PRO210) STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | IMMUNE SYSTEM, AFFINITY MATURATION
4ttd:L (THR146) to (PRO210) STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | IMMUNE SYSTEM, AFFINITY MATURATION
5hhm:E (HIS154) to (ALA243) CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L | HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM
5hhm:J (HIS154) to (TRP240) CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L | HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM
5hhp:A (GLU212) to (TRP274) CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-G4E | HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM
3qeq:A (GLU212) to (TRP274) THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE | MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM
3quy:D (HIS151) to (TRP237) STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
3quz:D (HIS151) to (TRP237) STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX | ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM
3r06:B (PRO151) to (LYS222) CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT | ANTIBODY, ANTI-CD3EPSILON, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM
3r06:D (PRO151) to (LYS222) CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT | ANTIBODY, ANTI-CD3EPSILON, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM
3r06:F (PRO151) to (LYS222) CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT | ANTIBODY, ANTI-CD3EPSILON, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM
3r06:H (PRO151) to (LYS222) CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT | ANTIBODY, ANTI-CD3EPSILON, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM